Yale researchers have redefined a key metric for diagnosing non-alcoholic fatty liver (NAFL) in young, lean, healthy people. Too much liver fat can lead to insulin resistance, type 2 diabetes, hepatic steatohepatitis (NASH), cirrhosis as well as an increased risk of cardiovascular disease. For the past 10 years, the diagnostic […]
Yale
Yale Cancer Center Study Suggests Improved Diagnostic Testing Needed to Guide HER2 Breast Cancer Treatment
A new study by researchers at Yale Cancer Center shows using current standard human epidermal growth factor receptor 2 (HER2) assays as a diagnostic test may result in a mis-assignment of patients for treatment for breast cancer with a promising new drug. The study analyzed current assays used to determine […]